These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 38003288)
41. RNA interference screening for the discovery of oncology targets. Quon K; Kassner PD Expert Opin Ther Targets; 2009 Sep; 13(9):1027-35. PubMed ID: 19650760 [TBL] [Abstract][Full Text] [Related]
42. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets. Mottini C; Napolitano F; Li Z; Gao X; Cardone L Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957 [TBL] [Abstract][Full Text] [Related]
44. Identification and Classification of Hubs in microRNA Target Gene Networks in Human Neural Stem/Progenitor Cells following Japanese Encephalitis Virus Infection. Mukherjee S; Akbar I; Bhagat R; Hazra B; Bhattacharyya A; Seth P; Roy D; Basu A mSphere; 2019 Oct; 4(5):. PubMed ID: 31578247 [TBL] [Abstract][Full Text] [Related]
45. Characterization of protein hubs by inferring interacting motifs from protein interactions. Aragues R; Sali A; Bonet J; Marti-Renom MA; Oliva B PLoS Comput Biol; 2007 Sep; 3(9):1761-71. PubMed ID: 17941705 [TBL] [Abstract][Full Text] [Related]
46. Yin and Yang of disease genes and death genes between reciprocally scale-free biological networks. Han HW; Ohn JH; Moon J; Kim JH Nucleic Acids Res; 2013 Nov; 41(20):9209-17. PubMed ID: 23935122 [TBL] [Abstract][Full Text] [Related]
47. [In vivo siRNA delivery to tumor cells and its application to cancer gene therapy]. Takahashi Y; Nishikawa M; Takakura Y Yakugaku Zasshi; 2007 Oct; 127(10):1525-31. PubMed ID: 17917414 [TBL] [Abstract][Full Text] [Related]
48. Equal opportunity for low-degree network nodes: a PageRank-based method for protein target identification in metabolic graphs. Bánky D; Iván G; Grolmusz V PLoS One; 2013; 8(1):e54204. PubMed ID: 23382878 [TBL] [Abstract][Full Text] [Related]
50. SPARK: Sparsity-based analysis of reliable k-hubness and overlapping network structure in brain functional connectivity. Lee K; Lina JM; Gotman J; Grova C Neuroimage; 2016 Jul; 134():434-449. PubMed ID: 27046111 [TBL] [Abstract][Full Text] [Related]
51. Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT. Collinson F; Royle KL; Swain J; Ralph C; Maraveyas A; Eisen T; Nathan P; Jones R; Meads D; Min Wah T; Martin A; Bestall J; Kelly-Morland C; Linsley C; Oughton J; Chan K; Theodoulou E; Arias-Pinilla G; Kwan A; Daverede L; Handforth C; Trainor S; Salawu A; McCabe C; Goh V; Buckley D; Hewison J; Gregory W; Selby P; Brown J; Brown J; Health Technol Assess; 2024 Aug; 28(45):1-171. PubMed ID: 39250424 [TBL] [Abstract][Full Text] [Related]
52. Galaxy and MEAN Stack to Create a User-Friendly Workflow for the Rational Optimization of Cancer Chemotherapy. Pires JG; da Silva GF; Weyssow T; Conforte AJ; Pagnoncelli D; da Silva FAB; Carels N Front Genet; 2021; 12():624259. PubMed ID: 33679888 [TBL] [Abstract][Full Text] [Related]
54. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes. Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038 [TBL] [Abstract][Full Text] [Related]
55. RNAi mediated silencing of STAT3/PD-L1 in tumor-associated immune cells induces robust anti-tumor effects in immunotherapy resistant tumors. Ganesh S; Kim MJ; Lee J; Feng X; Ule K; Mahan A; Krishnan HS; Wang Z; Anzahaee MY; Singhal G; Korboukh I; Lockridge JA; Sanftner L; Rijnbrand R; Abrams M; Brown BD Mol Ther; 2024 Jun; 32(6):1895-1916. PubMed ID: 38549376 [TBL] [Abstract][Full Text] [Related]
56. PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data. Piñeiro-Yáñez E; Reboiro-Jato M; Gómez-López G; Perales-Patón J; Troulé K; Rodríguez JM; Tejero H; Shimamura T; López-Casas PP; Carretero J; Valencia A; Hidalgo M; Glez-Peña D; Al-Shahrour F Genome Med; 2018 May; 10(1):41. PubMed ID: 29848362 [TBL] [Abstract][Full Text] [Related]
57. When the MET receptor kicks in to resist targeted therapies. Fernandes M; Jamme P; Cortot AB; Kherrouche Z; Tulasne D Oncogene; 2021 Jun; 40(24):4061-4078. PubMed ID: 34031544 [TBL] [Abstract][Full Text] [Related]
58. Non-invasive mapping of epileptogenic networks predicts surgical outcome. Corona L; Tamilia E; Perry MS; Madsen JR; Bolton J; Stone SSD; Stufflebeam SM; Pearl PL; Papadelis C Brain; 2023 May; 146(5):1916-1931. PubMed ID: 36789500 [TBL] [Abstract][Full Text] [Related]
59. Hubs with network motifs organize modularity dynamically in the protein-protein interaction network of yeast. Jin G; Zhang S; Zhang XS; Chen L PLoS One; 2007 Nov; 2(11):e1207. PubMed ID: 18030341 [TBL] [Abstract][Full Text] [Related]